Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
Mary K. Herrick, Malú G. Tansey
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Ai Huey Tan, Shen‐Yang Lim, Anthony E. Lang
Nature Reviews Neurology (2022) Vol. 18, Iss. 8, pp. 476-495
Closed Access | Times Cited: 209
Perspective on the current state of the LRRK2 field
Jean‐Marc Taymans, Matt Fell, Tim Greenamyre, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 70
The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson’s disease
Aurélie de Rus Jacquet, Melanie Alpaugh, Hélèna L. Denis, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 54
Parkinson’s Disease is Predominantly a Genetic Disease
Shen‐Yang Lim, Christine Klein
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 3, pp. 467-482
Open Access | Times Cited: 25
Leucine-Rich Repeat Kinases
Dario R. Alessi, Suzanne R. Pfeffer
Annual Review of Biochemistry (2024) Vol. 93, Iss. 1, pp. 261-287
Closed Access | Times Cited: 17
Pathological α-synuclein recruits LRRK2 expressing pro-inflammatory monocytes to the brain
Enquan Xu, Ravindra Boddu, Hisham Abdelmotilib, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 48
The systemic immune response in Parkinson’s disease: focus on the peripheral immune component
Johanne Lauritsen, Marina Romero‐Ramos
Trends in Neurosciences (2023) Vol. 46, Iss. 10, pp. 863-878
Open Access | Times Cited: 31
Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
Amica Corda Müller-Nedebock, Marieke C. J. Dekker, Matthew J. Farrer, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 30
Gastrointestinal syndromes preceding a diagnosis of Parkinson’s disease: testing Braak’s hypothesis using a nationwide database for comparison with Alzheimer’s disease and cerebrovascular diseases
Bo Konings, Luisa Villatoro, Jef Van den Eynde, et al.
Gut (2023) Vol. 72, Iss. 11, pp. 2103-2111
Open Access | Times Cited: 29
Gastrointestinal disorders in Parkinson’s disease and other Lewy body diseases
Masaaki Hirayama, Hiroshi Nishiwaki, Tomonari Hamaguchi, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 23
Conjugation of ATG8s to single membranes at a glance
Carmen Figueras-Novoa, Lewis Timimi, Elena Marcassa, et al.
Journal of Cell Science (2024) Vol. 137, Iss. 15
Open Access | Times Cited: 11
Possible linking and treatment between Parkinson’s disease and inflammatory bowel disease: a study of Mendelian randomization based on gut–brain axis
Beiming Wang, Xiaoyin Bai, Yingmai Yang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variant
Shen‐Yang Lim, Tzi Shin Toh, Jia Wei Hor, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Unraveling Parkinson’s Disease Neurodegeneration: Does Aging Hold the Clues?
Colin Coleman, Ian Martin
Journal of Parkinson s Disease (2022) Vol. 12, Iss. 8, pp. 2321-2338
Open Access | Times Cited: 34
Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study
Guanghui Cui, Shaojie Li, Hui Ye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures
Rekha Dhanwani, João Rodrigues Lima-Júnior, Ashu Sethi, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 29
Immunological shifts during early-stage Parkinson’s disease identified with DNA methylation data on longitudinally collected blood samples
Steven C. Pike, Matthew C. Havrda, Francesca Gilli, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease
Jerzy K. Kulski, Shingo Suzuki, Takashi Shiina, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Inflammatory bowel disease and risk of Parkinson’s disease: evidence from a meta-analysis of 14 studies involving more than 13.4 million individuals
Hongxing Li, Cui Zhang, Kai Zhang, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B
Prosenjit Pal, Matthew Taylor, Yuko P. Y. Lam, et al.
Science Advances (2023) Vol. 9, Iss. 50
Open Access | Times Cited: 16
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
Sujith Pavan, Arvind Prabhu, Sankar Prasad Gorthi, et al.
Folia Microbiologica (2022) Vol. 67, Iss. 5, pp. 693-706
Open Access | Times Cited: 19
Autophagy in Crohn’s Disease: Converging on Dysfunctional Innate Immunity
Kibrom M. Alula, Arianne L. Theiss
Cells (2023) Vol. 12, Iss. 13, pp. 1779-1779
Open Access | Times Cited: 12
Peripheral blood immune cells from individuals with Parkinson's disease or inflammatory bowel disease share deficits in iron storage and transport that are modulated by non-steroidal anti-inflammatory drugs
MacKenzie L. Bolen, Beatriz Maffini Gomes, B. Gill, et al.
Neurobiology of Disease (2025), pp. 106794-106794
Open Access
The interrelationship between intestinal immune cells and enteric α-synuclein in the progression of Parkinson’s disease
Yuan-Kai Cheng, Hao-Sen Chiang
Neurological Sciences (2025)
Closed Access
LRRK2 Mediates α-Synuclein-Induced Neuroinflammation and Ferroptosis through the p62-Keap1-Nrf2 Pathway in Parkinson’s Disease
Xinjie Liu, Zijian Zheng, Cheng Xue, et al.
Inflammation (2025)
Open Access
Page 1 - Next Page

Scroll to top